Product Categories

Elrazy Pharmaceuticals company shares have been registered

Elrazy Pharmaceuticals Co. S.A.E has the pleasure to Announce to shareholders that the shares Have Been Registered On 24/6/2012 in the Central Depository System of Misr for Clearing Settlement & Depository starting from this date, there will be no deals on the company shares except through an Account Statement All shareholders: Are kindly requested: to deposit their shares at any of the approved custodians.

Raziphemol infusion solution is to be introduced in the Egyptian market soon.

-Raziphemol is paracetamol solution for I.V. infusion.

-Raziphemol is used for short term treament of after surgery pain.

-Raziphemol is also used for short term treatment of hyperthermia

-Raziphemol is available in a pack of one 100 ml vial.

Pioglumet and Dicloferaz: soon in kuwait

-Pioglumet 15/850 FCT and Dicloferaz Dispersible tablets are in final steps for registration in kuwaiti MOH and will be launched during 2011 in kuwaiti pharmaceutical market.

Slim-lax into kuwaiti market

-After getting approved by kuwaiti MOH Slim-lax is launched in the market of kuwait as first step to rest of GCC.

-Slim-lax is a natural weight control herbals in form of tasteless tablets.

-Slim -lax is available through our agent in Kuwait Balsam Medical Co.

Pioglumet in the 5th Annual International Conference of AASD.

Pioglumet in the 5th Annual Pioglumet exhibits great success during its participation in the 5th Annual International Conference of The Arabic association for the Study of Diabetes and Metabolism (AASD).which is held in Cairo,Egypt during the
period 8-10,December,2010., in collaboration with the Royal college of physicians of Edinburgh,UK
Pioglumet attracts the majority of participants and visitors physicians who express their interest towards the added value of the combination
that Pioglumet gives to the pharmaceutical market of the Middle East.

Pioglumet in the 5th Annual

1 2